Karyopharm Therapeutics Inc. (KPTI)
Market Closed
17 Jul, 20:00
$
9. 51
+0.13
+1.3859%
$
227.76M Market Cap
- P/E Ratio
- Div Yield
202,600 Volume
-1.17 Eps
$ 9.38
Previous Close 
Want to track KPTI and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Karyopharm Therapeutics Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| JD Jim Dushek HARBOUR INVESTMENTS Inc. | 285 | $1,431.9 | $2,707.5 | $1,275.6 | 89.08% |
| SE Sima Elimelech Activest Wealth Management | 66 | $246.84 | $628.98 | $382.14 | 154.81% |
| EY Ellen York T. Rowe Price Investment Management Inc. | 1.54M | $7.85M | $14.7M | $6.84M | 87.18% |
 Li Peng China Universal Asset Management Co. Ltd. | 30,000 | $167,100 | $284,400 | $117,300 | 70.2% |
| WJ William Jollie Quent Capital LLC | 235 | $1,540.18 | $2,291.2 | $751.02 | 48.76% |
| OM Olga Maltseva Catalio Capital Management LP | 897,709 | $4.74M | $8.68M | $3.94M | 83.1% |
 Kevin Bresler TD Waterhouse Canada Inc. | 3,203 | $11,979.22 | $30,172.26 | $18,193.04 | 151.87% |
| AH Anders Hove Acorn Capital Advisors LLC | 287,826 | $1.6M | $2.72M | $1.12M | 69.75% |
| LC Leslie Childs MB Levis & Associates LLC | 100 | $374 | $948 | $574 | 153.48% |
